美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

三倍做多标普生物-Direxion

230.67

-12.4200-5.11%

成交量：26.63万

成交额：6,302.73万

市值：6.17亿

市盈率：- -

高：244.67

开：241.75

低：230.22

收：243.09

52周最高：341.93

52周最低：102.35

股本：267.45万

流通股本：267.45万

量比：0.44

换手率：9.96%

股息：0.90

股息率：0.39%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

医疗健康板块综述：市场观察

翰宇药业：HY3003注射液临床试验申请获FDA受理

复星联合健康险上海分公司被罚15万，涉编制虚假材料

艾力斯20厘米跌停单日蒸发市值超百亿中欧医疗健康混合A浮亏近2000万元

日本将把嗜睡症药物纳入公共医疗保险覆盖范围。

美国FDA扩大诺华一款用于治疗慢性皮肤病的药物适应症

诺华Rhapsido®获FDA批准成为首款症状性皮肤划痕症治疗药物

AbbVie的 Temab-A 获得两项 FDA 突破性疗法认定。

贝达药业：BPI-572270胶囊获美国FDA新药临床试验批准

医疗保健板块综述：市场评论

贝达药业：IND184065获美国FDA新药临床试验批准

前8个月医保统筹基金收入约2.07万亿元

前8个月医保统筹基金收入约2.07万亿元

医疗保健行业综述：市场观察

异动解读｜三倍做多标普生物科技盘下跌11.07%，生物科技板块承压明显

医疗保健行业综述：市场观察

医疗健康行业综述：市场观察

小摩：不太担心利率上升影响中国医疗健康行业继续看好生物科技及CXO

特朗普：感谢凯斯勒推动老年医疗创新

特朗普社媒动态

FDA 结束与冰山生菜相关的环孢子菌调查。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/LABU/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多标普生物-Direxion","latestPrice":230.67,"timestamp":1791833712343,"preClose":243.09,"halted":0,"volume":266295,"delay":0,"changeRate":-0.05109218807848951,"floatShares":2674486,"shares":2674486,"eps":0,"marketStatus":"交易中","change":-12.42,"latestTime":"10-12 15:35:13 EDT","open":241.75,"high":244.6716,"low":230.2215,"amount":63027329.0562,"amplitude":0.059443,"askPrice":230.8,"askSize":500,"bidPrice":230.15,"bidSize":30,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791835200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":243.09,"sharesOutstanding":3074486,"nav":242.822,"aum":649423578.22,"dividendRate":0.003899,"bidAskSpread":0.002692,"preHourTrading":{"tag":"盘前","latestPrice":242.43,"preClose":243.09,"latestTime":"09:29 EDT","volume":24862,"amount":6085203.2304,"timestamp":1791811795117,"change":-0.66,"changeRate":-0.002715,"amplitude":0.021844},"postHourTrading":{"tag":"盘后","latestPrice":242.18,"preClose":243.09,"latestTime":"19:59 EDT","volume":3944,"amount":956626.8862,"timestamp":1791590359878,"change":-0.91,"changeRate":-0.003743,"amplitude":0.004484},"volumeRatio":0.435193,"impliedVol":0.9552,"impliedVolPercentile":0.6614},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2674486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.435193,"shares":2674486,"dividePrice":0.8994,"high":244.6716,"amplitude":0.059443,"preClose":243.09,"low":230.2215,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":230.67,"committee":-0.886792,"eps":0,"divideRate":0.003899,"volume":266295,"delay":0,"ttmEps":0,"open":241.75,"prevYearClose":159.39,"prevWeekClose":243.09,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":257.38,"twentyDayClose":268.39,"sixtyDayClose":265.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1181612741","title":"医疗健康板块综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1181612741","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181612741?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 16:22","pubTimestamp":1791447759,"startTime":"0","endTime":"0","summary":"医疗健康板块最新市场观察汇总。摩根大通认为，近期提振该集团业绩的监管利好已经结束，费森尤斯医疗可能面临营业利润萎缩。分析师称，阿斯利康股价近期承压，一些投资者正在争论其当前困境是否可与瑞士同行罗氏在2022至2025年间的遭遇相提并论，当时罗氏因一系列令人失望的试验而受到市场惩罚。伯恩斯坦将阿斯利康目标价从200便士下调至198便士。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","BK4588","BK4581","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673022539","title":"翰宇药业：HY3003注射液临床试验申请获FDA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2673022539","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673022539?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 16:20","pubTimestamp":1791447617,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","IBBJ","PSYK","BK4585","BMED","MDTX","IBBQ","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673024801","title":"复星联合健康险上海分公司被罚15万，涉编制虚假材料","url":"https://stock-news.laohu8.com/highlight/detail?id=2673024801","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673024801?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 15:44","pubTimestamp":1791445453,"startTime":"0","endTime":"0","summary":"蓝鲸新闻10月8日讯，近日，上海金融监管局发布行政处罚决定书，剑指复星联合健康保险股份有限公司上海分公司及相关责任人。罚单显示，复星联合健康保险股份有限公司上海分公司的主要违法违规行为是：编制虚假材料。针对上述违法行为，上海金融监管局对其罚款15万元；对罗航宇（时任复星联合健康保险股份有限公司上海分公司总经理）警告并罚款2万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1791439929846922171","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4588","BK4585","LABU","BK4581","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673602313","title":"艾力斯20厘米跌停单日蒸发市值超百亿  中欧医疗健康混合A浮亏近2000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673602313","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673602313?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 13:59","pubTimestamp":1791439140,"startTime":"0","endTime":"0","summary":"2026年国庆假期后首个交易日，艾力斯因核心产品伏美替尼全球III期临床失利一字跌停，截至发稿报89.26元/股，单日蒸发市值超百亿元。建仓完成后，中欧医疗健康混合A每个季度均有小幅减仓动作。截至2026年6月30日，中欧医疗健康混合A累计已减持150.4万股，减持比例约16.4%，但仍持有764.9万股的仓位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-10-08/doc-iniunvxf4386122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","BK4585","IXJ","BK4581","XLV","BK4588","BK0239","159760","LABU","688578","BK4550","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673040690","title":"日本将把嗜睡症药物纳入公共医疗保险覆盖范围。","url":"https://stock-news.laohu8.com/highlight/detail?id=2673040690","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673040690?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 12:12","pubTimestamp":1791432751,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LABU","BK4581","BK4585","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673136042","title":"美国FDA扩大诺华一款用于治疗慢性皮肤病的药物适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2673136042","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673136042?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 10:52","pubTimestamp":1791427935,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4578","LU0208291251.USD","IE0009355771.USD","IE00B2B36J28.USD","BK4532","MEDX","PPH","LU0320765489.SGD","IE0002141913.USD","BK4585","LABU","LU0070302665.USD","NVS","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0211331839.USD","BK4588","IE00B4R5TH58.HKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011362","title":"诺华Rhapsido®获FDA批准 成为首款症状性皮肤划痕症治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011362","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011362?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 23:54","pubTimestamp":1791388472,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0208291251.USD","BK4585","BK4578","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","MEDX","IE00BJT1NW94.SGD","BK4007","LU0070302665.USD","BK4532","PPH","LU0211331839.USD","LABU","BK4588","NVS","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018172","title":"AbbVie的 Temab-A 获得两项 FDA 突破性疗法认定。","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018172","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018172?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 20:30","pubTimestamp":1791376250,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673099663","title":"贝达药业：BPI-572270胶囊获美国FDA新药临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2673099663","media":"同花顺","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673099663?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 16:46","pubTimestamp":1791362760,"startTime":"0","endTime":"0","summary":"人民财讯10月7日电，贝达药业(300558)10月7日公告，公司全资子公司景曜生物申报的BPI-572270胶囊药品临床试验申请获得美国FDA批准。该药品拟用于晚期实体瘤。 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261007/c680447508.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261007/c680447508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["IBBQ","300558","MDTX","BK4588","LABU","BK0060","BK4585","BMED","IBBJ","PSYK","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121674763","title":"医疗保健板块综述：市场评论","url":"https://stock-news.laohu8.com/highlight/detail?id=1121674763","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121674763?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 16:24","pubTimestamp":1791361487,"startTime":"0","endTime":"0","summary":"最新一期的医疗保健板块市场评论。她指出，管理层预计10月和11月平均售价将呈上升趋势，因中国手套制造商展现出更强的自律性，供需也趋于平衡。她表示，成本效率也应支撑约8%至12%的可持续税前利润率。由于2026财年盈利超出预期，Wong将顶级手套2027至2028财年盈利预测上调113%至116%。马来亚银行将顶级手套目标价从0.71林吉特上调至0.73林吉特，同时维持卖出评级。该股上涨2.3%，报0.90林吉特。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","FEBU","JOYT","BVA.SI","BK6103","BK4588","BK4585","BK4581","DECU","LABU","VOTE","RGLO","XBI","PMDE","BK6511","VGFPF","GXDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673096100","title":"贝达药业：IND184065获美国FDA新药临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2673096100","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673096100?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 16:16","pubTimestamp":1791360980,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4585","BK4588","PSYK","BMED","IBBJ","IBBQ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673906252","title":"前8个月医保统筹基金收入约2.07万亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673906252","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673906252?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 10:30","pubTimestamp":1791340225,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据新华社报道，国家医保局日前发布数据，2026年1月至8月，我国基本医疗保险（含生育保险）统筹基金总收入20727.72亿元，基本医疗保险（含生育保险）统筹基金总支出15504.14亿元，医保基金整体运行平稳。数据显示，在基本医疗保险（含生育保险）统筹基金收入方面，职工基本医疗保险（含生育保险）统筹基金收入12813.17亿元，城乡居民基本医疗保险统筹基金收入7914.55亿元。2026年前8个月，职工基本医疗保险（含生育保险）统筹基金支出8893.49亿元，其中生育保险基金待遇支出889.29亿元；城乡居民基本医疗保险统筹基金支出6610.65亿元。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/Y2Y0ZjIxMzUyMzg0MDEwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/Y2Y0ZjIxMzUyMzg0MDEwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993194","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","XBI","BK4581","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673062881","title":"前8个月医保统筹基金收入约2.07万亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673062881","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673062881?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 10:21","pubTimestamp":1791339690,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4585","BK4581","XLV","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118919341","title":"医疗保健行业综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1118919341","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118919341?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 04:54","pubTimestamp":1791320069,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场观察。“赛诺菲现在可以着手将其300亿至400亿欧元的资产负债表能力投入到业务拓展中，”分析师称。分析师称，Berenberg接下来关注的下一个更新数据是frexalimab治疗多发性硬化症的后期试验，以及brivekimig治疗皮肤疾病化脓性汗腺炎的中期试验，均预计于2027年下半年公布。赛诺菲股价上涨1%。泰国医疗保健公司的盈利不太可能因近期部分地区洪水而受到大幅拖累，马来亚银行的Nontapat Sahakitpinyo在一份报告中表示。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","BK4585","XBI","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114542097","title":"异动解读｜三倍做多标普生物科技盘下跌11.07%，生物科技板块承压明显","url":"https://stock-news.laohu8.com/highlight/detail?id=1114542097","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114542097?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 01:40","pubTimestamp":1791308458,"startTime":"0","endTime":"0","summary":"10月7日，三倍做多标普生物科技-Direxion盘中下跌11.07%，报228.895美元/股，成交额1.98亿美元。该ETF提供标普生物科技精选行业指数的三倍杠杆敞口，其跌幅远大于同期标普生物科技精选行业指数的波动，反映出杠杆效应下对生物科技板块回调的放大作用。近期生物科技板块情绪波动较大，美国利率预期变化持续对高久期、零收入型生物科技公司形成压制，投资者对加息担忧重燃，导致杠杆型生物科技产品出现显著回撤。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"生物科技板块承压，三倍做多ETF显著下跌","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160573907","title":"医疗保健行业综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1160573907","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160573907?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 00:26","pubTimestamp":1791304017,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场观察汇总。赛诺菲股价上涨1%。该美国投行表示，此前市场对盐野义制药可能寻求何种并购存在一些担忧。1749 ET - 杰富瑞认为，CSL与Alentis Therapeutics达成联合开发和推广一种罕见肾脏及肝脏疾病疗法的协议，体现了CSL当前的研发理念。该疗法名为lixudebart，正在一项2期试验中用于评估治疗ANCA相关性血管炎和快速进展性肾小球肾炎患者的效果。杰富瑞估计，该疾病在美国的年均可及市场总额为9亿至16亿美元，并补充称这一评估较为保守。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4581","XLV","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197928159","title":"医疗健康行业综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1197928159","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197928159?lang=zh_cn&edition=fundamental","pubTime":"2026-10-06 16:25","pubTimestamp":1791275116,"startTime":"0","endTime":"0","summary":"医疗健康板块最新市场观察。“赛诺菲现在可以着手将300亿至400亿欧元的资产负债表能力用于业务拓展，”分析师称。由于赛诺菲与再生元将联合开发的候选药物尚处早期阶段，这家法国药企近期可期的关键研究结果有限，Berenberg指出。赛诺菲股价上涨1%。泰国医疗健康公司的盈利不太可能受到近期部分地区洪灾的严重拖累，马来亚银行的Nontapat Sahakitpinyo在一份报告中表示。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","XBI","XLV","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673035134","title":"小摩：不太担心利率上升影响中国医疗健康行业 继续看好生物科技及CXO","url":"https://stock-news.laohu8.com/highlight/detail?id=2673035134","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673035134?lang=zh_cn&edition=fundamental","pubTime":"2026-10-06 11:32","pubTimestamp":1791257520,"startTime":"0","endTime":"0","summary":"另外，该行预期本轮加息周期将于12月再加息一次后结束，而非延续至明年的长期紧缩，因此对利率上升影响中国医疗健康估值并不太担心，并继续看好生物科技及CXO子板块。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268","KURE","06990","LU1974910355.USD","LABU","XLBI","CXO","IEIH","XBI","159760","EQRR","IE0034235295.USD","JPO","LU1670627923.USD","XLV","IBBJ","MEDX","VHT","IXG","GDOC","FNCL","03696","LNGR","159837","TRUF","LU0708995153.HKD","KBWB","02269","IYF","TFNS","VFH","JPMO","LU2168564065.EUR","UYG","XLF","01548","PEX","SYNB","LU0345769631.USD","02359","LU0345769128.USD","FTXO","IE00BKDWB100.SGD","HBImain","IYG","LU0976567544.SGD","LU0572944931.SGD","WX","IXJ","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109627217","title":"特朗普：感谢凯斯勒推动老年医疗创新","url":"https://stock-news.laohu8.com/highlight/detail?id=1109627217","media":"特朗普社媒动态","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109627217?lang=zh_cn&edition=fundamental","pubTime":"2026-10-06 11:04","pubTimestamp":1791255864,"startTime":"0","endTime":"0","summary":"美国总统唐纳德·特朗普10月6日在社交媒体X上发文，感谢并赞扬其老龄化医疗保健顾问霍华德·凯斯勒为65岁及以上美国老年人所做的工作。特朗普在帖文中称凯斯勒是“非常成功的创业者和创新者”，曾帮助转型金融服务业，如今将“同样的远见、精力和经验”带入医疗保健领域。特朗普强调“Our Seniors built this Country. They deserve the BEST Healthcare in the World, and we are going to make sure they get it.”（我们的老年人建设了这个国家。）他最后对凯斯勒说：“Keep up the great work!”","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGCV","HBMD","BK4211","HEAL","BK4585","XBI","BK4550","LNGR","BK4581","NOBL","IXJ","DTEC","LABU","BK4588","XLV","VHT","THMZ","GINN","TCAF","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672746826","title":"FDA 结束与冰山生菜相关的环孢子菌调查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2672746826","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672746826?lang=zh_cn&edition=fundamental","pubTime":"2026-10-03 02:57","pubTimestamp":1790967471,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}